Monograph Capital Overview
Monograph Capital is a venture capital firm with offices in London and San Francisco, dedicated to funding innovative life sciences companies. They focus on transforming promising scientific discoveries into life-changing treatments globally. The firm leverages deep medical expertise, extensive pharmaceutical relationships, and seasoned operational experience to build value for their partners and investors, aiming to deliver better health outcomes for patients.
Is Monograph Capital the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Monograph Capital, along with a list of other relevant VCs, is available on Hopohopo.io.
Monograph Capital
Investment focus
Product type
- Drugs / Pharma
Industries / verticals
- BioTech & Life Sciences
- Digital & Consumer health
- MedTech & Devices
- PharmaTech
Investment role
Lead and follow
Stages
Series A, Series B or later
First ticket size
US$3,000,000 - US$10,000,000
Contact information
Co-founder and Partner, Monograph Capital
Charles Conn
Partner
Tim Funnell
Associate
Melisa Guven
Head of Finance
Nishat Miah
EA to Founder and Partner
Jo T.
How to approach funds like Monograph Capital
When approaching Monograph Capital, founders should highlight the translational potential of their science and demonstrate a clear path from discovery to patient impact. Emphasize robust clinical validation plans, regulatory strategy, and how your team’s expertise bridges the gap between research and real-world application. Articulate how your company can leverage strategic partnerships within the pharmaceutical ecosystem to accelerate development and maximize patient benefit.
Find the best-fitting investors for your startup
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.
